Pediatric Concussion Outcomes

Treatment for Post-concussive Headache: A Randomized, Placebo-controlled, Double Blinded Trial

This is a randomized, placebo-controlled, double-blinded trial in which subjects with a post concussive headache meeting inclusion criterion will be assigned to one of two treatment groups: placebo or nortriptyline. Each group will be evaluated at week 0 and again each week for the next 4 weeks of treatment with a concussion survey that rates their symptoms. At the end of 4 weeks the study will be unblinded. It is hypothesized that the addition of nortriptyline to the standard headache treatments will result in more rapid decrease of symptom score than with placebo.

Pediatric Concussion Outcomes

Recruitment

Summary

Participation Requirements

Description

Tracking Information